Chief Financial Officer

Senior Vice President, Head of Research

Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025

Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis

KYVERNA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Kyverna Therapeutics announces updated data from Phase 1 IITs of KYV-101

GL/AP Accounting Consultant

Kyverna Therapeutics is seeking an experienced GL/AP Accounting Consultant to manage various accounting processes. This role involves overseeing the offshore accounts payable process, general ledger accounting, and contributing to financial systems implementation and process enhancements.

GL/AP Accounting Consultant (Contractor)

VP of Human Resources

Sr. Director, Talent Acquisition

Sign up with Google

Sign in with Google